Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Electrophysiologists have been using digital technologies for monitoring arrhythmias and pacemakers for years – but in this era of wearables and apps – what does that mean for the future of arrhythmia care? Dr. Oussama Wazni, Section Head Electrophysiology and Pacing, and Dr. Khaldoun Tarajki, Director of the Center for Digital Health and Telemedicine, discuss what we have learned from studies, da...

Dr. Eric Roselli and Dr. Amit Goyal discuss strategies and novel advances in the treatment of aortitis.

Carotid artery disease patient management involves screening, monitoring, prevention of progression, and interventional or surgical treatment when needed. Vascular specialists Dr. Sean Lyden, Dr. Scott Cameron and Dr. Chris Bajzer discuss the Cleveland Clinic multidisciplinary approach to care and decision making, collaboration with referring physicians, and new innovations and research involving...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to insert a new aortic valve in patients with aortic stenosis. While risk is low, stroke remains an important risk for this procedure. Dr. Samir Kapadia, Chairman of Cardiovascular Medicine, explains the goal of the sentinel device during the TAVR procedure to lessen risk of stroke. A large multicenter randomized...

Christopher Smolock, MD discusses new devices, old problems for managing complicated arterial access.

Hypertrophic Cardiomyopathy Center specialists have recently published three papers related to a wide range of patients with HCM, including the elderly, pediatric and general population. Dr. Milind Desai, Director of the HCM Center reviews the implications for diagnosis, management and risk stratification based on the results of these papers.

Dr. John Rickard joins Dr. Eric Roselli to discuss the cardiac resynchronization therapy – heart failure optimization clinic and key takeaways from a recent Tall Rounds® session.

The ACC/AHA released new valve guidelines. Dr. Lars Svensson and Dr. Marc Gillinov talk about highlights addressing management of patients with valvular heart disease including TAVR (TAVI); valve surgery; timing of treatment, valve choice, valve repair, surgical approach, and how the guidelines address the aorta and the tricuspid valve.

Dr. Eric Roselli and Dr. Jerry Estep highlight the Heart, Vascular & Thoracic Institute's perspective on the multidisciplinary approach to COVID-19, the implications, what we've learned, and emerging treatement strategies.

In honor of Valve Disease Awareness Day, valve specialists Dr. Paul Cremer and Dr. Christine Jellis answer questions they often get from clinicians referring patients for valve disease treatment. Topics include patient considerations for MitraClip, use of TMVR, TAVR for aortic regurgitation, and tricuspid valve regurgitation options. In addition the doctors discuss how anatomy, imaging and a team...

Dr. Edward Soltesz leads a discussion on Extracorporeal membrane oxygenation (ECMO) in the adult cardiac patient.

Dr. Walid Saliba provides an update on the treatment of left atrial appendage.

Dr. W.H. Wilson Tang provides an overview of novel approaches defining HFpEF and management strategies.

Patients who present with angina or even myocardial infarction may show mild or no coronary artery disease on coronary angiography. This condition, called INOCA or ischemia with no obstructive coronary arteries, is caused by microvascular dysfunction or vasospastic disorders. Dr. Khaled Ziada, a cardiologist at Cleveland Clinic specializes in this disorder and discuss how this condition is diagnos...

Dr. Saliba and Dr. Wazni discuss the challenges of patients who would like to stop anticoagulation after atrial fibrillation ablation. The OPTION study is a research trial looking at the safety and effectiveness of the WATCHMAN device used for left atrial appendage closure vs. oral anticoagulants in patients with non valvular atrial fibrillation.

Dr. Eric Roselli and Dr. Amit Goyal discuss cardio-obstetrics and a team based approach to patient care.

Aorta Center vascular surgeon Dr. Sean Lyden and cardiovascular medicine specialist Dr. Scott Cameron talk about information providers may find helpful, such as screening guidelines; risk factors; unusual findings during a physical exam; when patients should be referred to an aortic specialist; and treatment options from minimally invasive to open approaches

Dr. Eric Roselli discusses thoracic aortic aneurysms, highlighting two case presentations and root replacement operative considerations.

Dr. Steve Nissen, Chief Academic Officer, Cleveland Clinic Miller Family Heart, Vascular & Thoracic Institute talks about three trials presented at the 2020 AHA Scientific Sessions: the STRENGTH trial (omega 3 fatty acid’s impact on cardiovascular events) ; STOP AF trial (medication vs. ablation in treating patients with new onset atrial fibrillation); and the RHAPSODY trial (randomized trial...

Dr. Eric Roselli and Dr. Amit Goyal discuss cardiac arrest and deep dive on a patient rescue.

Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial, a pivotal Phase 3 trial that evaluated rilonacept, an interleukin 1-α and 1-β inhibitor, compared with placebo among patients with recurrent pericarditis. Study design and findings are provided, as well as implications for future care for patients with pericarditis.

Dr. Eric Roselli and Dr. Amit Goyal discuss 2000 Heart Transplants at the Cleveland Clinic.

Many thoracic surgery cases are now being performed using robotically assisted surgery. Dr. Sudish Murthy and Dr. Usman Ahmad discuss how the robot is used and the types of procedures that benefit from this minimally invasive approach.

The ACC CVD in Women Committee published a summary of recommendations for primary prevention of cardiovascular disease specific to women. Dr. Leslie Cho, Director of the Women’s Cardiovascular Center and Co-Section Head, Preventive Cardiology, discusses what clinicians should know about the updated guidelines. She addresses unique risk factors that pertain to women, as well as how traditional risk...

Jerry Estep, MD, Section Head of Heart Failure and Transplantation, discusses a Tall Rounds® on the topic of Cardiogenic Shock, focusing on the team approach that is required to provide optimal care. Featuring a presentation from Venu Menon MD, Section Head of Clinical Cardiology, defining cardiogenic shock and including lessons learned from the SHOCK trial and classifications of shock impact on t...